The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence

Robert Hester, Nicole Lee, Amy Pennay, Suzanne Nielsen, Jason Ferris

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)


The cognitive benefits of modafinil to patients undergoing 7-day inpatient withdrawal from methamphetamine (MA) dependence were examined as part of a double-blind, randomized, placebo-controlled pilot trial. Recent evidence has identified modafinil-related improvements in treatment outcomes for MA-dependent patients; however, the benefits to cognition function, which is critical to treatment success but known to be impaired, has yet to be examined
Original languageEnglish
Pages (from-to)489 - 497
Number of pages9
JournalExperimental and Clinical Psychopharmacology
Issue number6
Publication statusPublished - 2010

Cite this